Cassava Sciences Faces Controversy but Analysts See Potential
Oct 30, 2024
Alzheimer's Investment Portfolios
Athira Pharma Shares Insightful Data on Fosgonimeton for Alzheimer's and Parkinson's Treatment at AD/PD™ 2024
Mar 9, 2024
Cognition Therapeutics' Research Elucidates Key Proteins in Alzheimer’s Therapy
Feb 7, 2024
Cognition Therapeutics CEO’s Letter Forecasts Key Milestones for Alzheimer's Disease Trial
Jan 5, 2024
Athira Pharma Reports Promising Preclinical Data for Alzheimer's Treatment Candidate Fosgonimeton
Nov 15, 2023
Athira Pharma Showcases Neuroprotective Benefits of Fosgonimeton in Alzheimer's Research
Nov 15, 2023